OssDsign PROPEL spine fusion registry tops 400 patients for Catalyst bone graft study

Reuters2026/09/09 07:59

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

OssDsign reported PROPEL, a real-world spine fusion registry for its Catalyst bone graft, has enrolled more than 400 patients.
Results were already presented from an earlier subset of patients, showing strong fusion outcomes in a complex, high-risk population.
Patients also recorded broad health improvements, with no product-related safety issues flagged in the published analysis.
The larger enrollment strengthens the company’s clinical evidence base, supporting commercial positioning against other graft options in spine surgery.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OssDsign AB published the original content used to generate this news brief via Cision (Ref. ID: 202609090358BITN____UKPR__SV_20260907-BIT-6973-0) on September 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

OssDsign PROPEL spine fusion registry tops 400 patients for Catalyst bone graft study

You may also like

Crypto prices